Aprogen Healthcare & Games Inc Cash Flow Conversion Efficiency

Latest as of September 2025: 0.002x

Aprogen Healthcare & Games Inc cash flow conversion efficiency. Based on the latest financial reports, Aprogen Healthcare & Games Inc (109960) has a cash flow conversion efficiency ratio of 0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩699.57 Million ≈ $474.09K USD) by net assets (₩309.52 Billion ≈ $209.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Aprogen Healthcare & Games Inc (2013–2024)

Cash flow conversion efficiency of Aprogen Healthcare & Games Inc from 2013 to 2024. This chart illustrates how Aprogen Healthcare & Games Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 109960 stock price for real-time trading data and today's change.

Aprogen Healthcare & Games Inc Cash Flow Conversion Ratio Explained

Aprogen Healthcare & Games Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Aprogen Healthcare & Games Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aprogen Healthcare & Games Inc ranked by their cash flow conversion efficiency. Also see market value of Aprogen Healthcare & Games Inc for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
ESSA Bancorp Inc NASDAQ:ESSA	0.016x
GRM Overseas Limited NSE:GRMOVER	0.004x
Quantum eMotion Corp. V:QNC	-0.051x
Shanghai Hongda New Material Co Ltd SHE:002211	0.026x
OP Bancorp NASDAQ:OPBK	0.105x
Izmir Demir Celik Sanayi AS IS:IZMDC	-0.076x
Xsolla SPAC 1 Class A Ordinary Shares NASDAQ:XSLL	-0.001x
Sol Gel Technologies Ltd NASDAQ:SLGL	0.039x

Annual Cash Flow Conversion Efficiency for Aprogen Healthcare & Games Inc (2013–2024)

The table below shows the annual cash flow conversion efficiency of Aprogen Healthcare & Games Inc from 2013 to 2024. Review 109960 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩301.81 Billion ≈ $204.53 Million	₩4.71 Billion ≈ $3.19 Million	0.016x	+169.57%
2023-12-31	₩287.26 Billion ≈ $194.68 Million	₩1.66 Billion ≈ $1.13 Million	0.006x	-93.34%
2022-12-31	₩198.89 Billion ≈ $134.78 Million	₩17.28 Billion ≈ $11.71 Million	0.087x	+245.56%
2021-12-31	₩222.62 Billion ≈ $150.86 Million	₩-13.29 Billion ≈ $-9.01 Million	-0.060x	-508.77%
2020-12-31	₩231.83 Billion ≈ $157.11 Million	₩3.39 Billion ≈ $2.29 Million	0.015x	+211.79%
2019-12-31	₩210.50 Billion ≈ $142.65 Million	₩986.07 Million ≈ $668.25K	0.005x	-76.65%
2018-12-31	₩217.46 Billion ≈ $147.37 Million	₩4.36 Billion ≈ $2.96 Million	0.020x	+213.50%
2017-12-31	₩114.81 Billion ≈ $77.80 Million	₩734.70 Million ≈ $497.89K	0.006x	+100.57%
2016-12-31	₩8.64 Billion ≈ $5.86 Million	₩-9.71 Billion ≈ $-6.58 Million	-1.124x	-759.29%
2015-12-31	₩15.08 Billion ≈ $10.22 Million	₩-1.97 Billion ≈ $-1.34 Million	-0.131x	-147.38%
2013-12-31	₩4.40 Billion ≈ $2.98 Million	₩1.22 Billion ≈ $823.57K	0.276x	--

About Aprogen Healthcare & Games Inc

KQ:109960 Korea Pharmaceuticals

Market Cap

$209.26 Million

₩308.78 Billion KRW

Market Cap Rank

#16151 Global

#577 in Korea

Share Price

₩1728.00

Change (1 day)

-0.12%

52-Week Range

₩150.00 - ₩2300.00

All Time High

₩20250.00